(XAIR) – Trader Talk
-
Beyond Air, Inc. (XAIR) Climbs 38% After FDA Approval of LungFit to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
-
Beyond Air, Inc. (XAIR) Shares Up 10% Following Insider Buys of 375K Shares
-
-
Back to XAIR Stock Lookup